Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
January 7, 2026
Lucid Diligence Brief: Amgen acquires Dark Blue Therapeutics
January 5, 2026
Lucid Diligence Brief: Insilico Medicine × Servier oncology collaboration
January 5, 2026
Endocrinology Today—January 5, 2026
January 5, 2026
Obesity Video Recap—January 5, 2026
January 5, 2026
Obesity Today—January 5, 2026
January 5, 2026
Oncology Video Recap—January 5, 2026
January 5, 2026
Oncology Today—January 5, 2026
January 5, 2026
Hematology Today—January 5, 2026
January 4, 2026
Lucid Diligence Brief: Zelgen × AbbVie option-to-license on alveltamig
January 3, 2026
Lucid Diligence Brief: Neuralink’s 2026 high-volume BCI plan
January 2, 2026